Literature DB >> 7357738

The relationship between the cholesterol content and subfraction distribution of plasma high-density lipoproteins.

J Shepherd, C J Packard, J M Stewart, B D Vallance, T D Lawrie, H G Morgan.   

Abstract

High density lipoprotein subfractions (HDL2 and HDL3) were separated from the plasma of 25 healthy volunteers (13 males, 12 females) rate zonal ultracentrifugation. The rotor elution profile, measured at 280 nm, was used with the specific extinction coefficient for each subfraction (HDL2, 0.60 +/- 0.11 mg protein/A280nm, HDL3, 0.86 +/- 0.10 mg protein/A280nm (n=25) to calculate their plasma concentration. Their protein and lipid composition were also determined by chemical analysis. Plasma lipids, lipoprotein cholesterol, apolipoprotein A-I, apolipoprotein A-II and apolipoprotein B levels were measured in the same subjects and correlated with the HDL subfraction concentrations. HDL cholesterol and apolipoprotein A-I concentrations correlated significantly (p less than 0.01 and 0.02 respectively) with plasma HDL2, but not with HDL3. Indeed, the significantly higher levels of HDL cholesterol and apolipoprotein A-I in the female group could be attributed entirely to an increase in circulating HDL2. This data supports the proposal that the latter subfraction is the major contributor to the anti-atherogenic role of plasma HDL.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7357738     DOI: 10.1016/0009-8981(80)90055-8

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates.

Authors:  E A Brinton; S Eisenberg; J L Breslow
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

2.  High-density lipoprotein subfractions in normolipidemic individuals without clinical atherosclerosis lipoprotein subfractions in an adult population.

Authors:  Fabio L Sodré; Vera S Castanho; Lucia N Castilho; Silvia de Barros-Mazon; Eliana C de Faria
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

3.  Current clinical laboratory practice: investigation of plasma lipids--which tests and when?

Authors:  W J Marshall; F C Ballantyne
Journal:  Br Med J (Clin Res Ed)       Date:  1986-06-21

4.  Isolation of a high-density-lipoprotein conversion factor from human plasma. A possible role of apolipoprotein A-IV as its activator.

Authors:  P J Barter; O V Rajaram; L B Chang; K A Rye; P Gambert; L Lagrost; C Ehnholm; N H Fidge
Journal:  Biochem J       Date:  1988-08-15       Impact factor: 3.857

5.  [Apolipoproteins and lipoproteins with differing physical activity and performance capability].

Authors:  T Kullmer; W Kindermann
Journal:  Klin Wochenschr       Date:  1985-11-04

6.  Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoprotein.

Authors:  Andrea J Luthi; Nicholas N Lyssenko; Duyen Quach; Kaylin M McMahon; John S Millar; Kasey C Vickers; Daniel J Rader; Michael C Phillips; Chad A Mirkin; C Shad Thaxton
Journal:  J Lipid Res       Date:  2015-02-04       Impact factor: 5.922

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.